Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of NLRP3 Inflammasone and Hypoxia in the Severity of Osteoporosis in Patients With Bronchiectasis

NCT03467035 is registered in ClinicalTrials.gov with Chun-Hua Wang, MD as lead sponsor.

NCT NCT03467035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03467035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of NLRP3 Inflammasone and Hypoxia in the Severity of Osteoporosis in Patients With Bronchiectasis
Lead sponsor
Chun-Hua Wang, MD
Phase
Observational
Overall status
Unknown status
Start date
December 21, 2017
Completion date
June 30, 2019
Enrollment
80 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bronchiectasis adult, osteoporosis, osteopenia